Alpha Cubed Investments LLC lowered its stake in shares of Johnson and Johnson (NYSE: JNJ) by 29.8% in the undefined quarter, according to the company in its most recent disclosure with the SEC. The f
These companies have a long history of dividend growth, spanning more than 50 years. Passive income is something that rewards investors in any market environment.
Private Wealth Asset Management LLC lowered its position in shares of Johnson and Johnson (NYSE: JNJ) by 25.9% in the third quarter, according to the company in its most recent 13F filing with the SEC
Johnson & Johnson could become the second biopharma company to achieve $100 billion in annual sales. The healthcare leader has a robust and diversified business that can support its dividend program.
Johnson & Johnson: Fraud Claim Dismissal Today Is Not A Sign Talc Litigation Is Over
Stock News Warsh tapped for Fed: U.S. markets (SPY) steadied after President Donald Trump named former governor Kevin Warsh to succeed Jerome Powell as Federal
AMPLITUDE is the first clinical trial to evaluate potential therapies for patients with mHSPC and known HRR gene alterations, with positive results supporting the niraparib-based combination regimen a
Ballentine Partners LLC increased its stake in shares of Johnson and Johnson (NYSE: JNJ) by 5.5% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Comm
Bank of New York Mellon Corp grew its holdings in Johnson and Johnson (NYSE: JNJ) by 3.5% during the undefined quarter, according to the company in its most recent filing with the SEC. The fund owned
A U.S. district judge on Thursday dismissed a lawsuit alleging Johnson & Johnson committed fraud by repeatedly attempting to use a shell company's bankruptcy to resolve tens of thousands of lawsuits c
Susan Bao's large-cap JPMorgan fund has outperformed the S&P 500 over many years. She's bullish on stocks, focused on bargains.
Stock News Amazon trims 16,000 roles: Amazon (AMZN) will eliminate about 16,000 positions as part of ongoing restructuring, offering most U.S. staff 90 days for
Johnson & Johnson leads Zacks' latest Analyst Blog as new research highlights earnings beats, growth drivers, and risks across major and micro-cap stocks.
Chilton Capital Management LLC increased its holdings in shares of Johnson and Johnson (NYSE: JNJ) by 44.0% during the third quarter, according to its most recent disclosure with the Securities and Ex
Clarendon Private LLC bought a new stake in shares of Johnson and Johnson (NYSE: JNJ) during the undefined quarter, according to the company in its most recent disclosure with the Securities and Excha
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE